# Bridge to Life

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bridge-to-life

- Industry: Medical Devices & Equipment
- Headquarters: Duluth, US
- Website: www.bridgetolife.com
- Latest round: Series C (Aug 12, 2026)
- Investors on record: 3

## About

Founded in 2005 and based in Illinois, US, Bridge to Life Ltd. operates as a supplier of organ preservation solutions and organ perfusion technologies. In August 2026, Bridge to Life Ltd. raised USD 110 million in series C and venture debt funding from new Soleus Capital and Lauxera Capital Partners.

Bridge to Life Ltd. provides supplies for organ preservation solutions to patients that focus on collaboration with surgeons and transplant professionals.

The company will use the August 2026 funding to accelerate the U.S. commercial rollout of the VitaSmart HOPE System, expand its field team, secure working capital, advance a new organ viability assessment tool, broaden its organ preservation portfolio, and develop next-generation organ transport systems.

## Funding rounds

- Series C, Aug 12, 2026 — Soleus Capital, Lauxera Capital Partners
- Series A, Aug 19, 2021 — Perceptive Advisors

## Investors

- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series A
- Soleus Capital (https://capitalatlas.ai/funds/soleus-capital) — Series C
- Lauxera Capital Partners (https://capitalatlas.ai/funds/lauxera-capital-partners) — Series C